The State Drug Administration requires strict investigation of the online sales of "beautiful pupils"

On August 30, the State Drug Administration issued the "Notice on the Development of Special Rectification Actions for the Special Rectification of the Production and Operation Behavior of Devitaring and Victoring Color Institutes", which announced that it will organize the development of 3 months from September 1, 2022 to the country Special rectification actions of "standardized decorative color contact lenses" production and operation behavior.

Decorative color contact lenses, also known as "beautiful pupils" in the market. With the improvement of people's living standards and aesthetic needs, the demand for "beautiful pupils" has increased, and e -commerce platforms have become the main channel for "beautiful pupils" sales.

The "Notice" requires that the drug supervision departments at all levels should severely crack down on production and operation of unregistered decorative color contact lenses, online illegal sales, non -medical device production and operation qualifications, and over -range operations.

This strict investigation focused on the responsibility of a third -party network platform.

The "Notice" requires that third -party platform providers should monitor the sales behavior and information of decorative color contact lenses on the platform. If the e -commerce platform discovers that the enterprises that settled in, there are illegal acts such as over -range operations, release of false information, and exaggerated publicity, they should immediately stop online transactions and save records and report to the pharmaceutical regulatory department.

For major e -commerce platforms, this series of rectification work means strict rectification of "beautiful pupils" products.

The State Drug Administration stated that the organizational inspection team will go to various places to conduct supervision and inspection, and ask the drug supervision departments at all levels to summarize the special rectification work by December 10 this year to report to the Equipment Supervision Department of the State Drug Administration.

#####

- END -